Single-Nucleotide Polymorphisms Associated With Age-Related Macular Degeneration and Lesion Phenotypes in the Comparison of Age-Related Macular Degeneration Treatments Trials.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  JAMA ophthalmology

• Publication date

  2016-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/jamaophthalmol.2016.0669PMID 27099955PMCID PMC6005698
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Growth of geographic atrophy in the comparison of age-related macular degeneration treatments trials.

  2015cited by this paper
• MMP20 and ARMS2/HTRA1 Are Associated with Neovascular Lesion Size in Age-Related Macular Degeneration.

  2015cited by this paper
• Environmental and genetic risk factors for retinal angiomatous proliferation

  2014cited by this paper
• Risk of scar in the comparison of age-related macular degeneration treatments trials.

  2014cited by this paper
• Risk of geographic atrophy in the comparison of age-related macular degeneration treatments trials.

  2014cited by this paper
• Pharmacogenetic associations with vascular endothelial growth factor inhibition in participants with neovascular age-related macular degeneration in the IVAN Study.

  2013cited by this paper
• Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration.

  2013cited by this paper
• Macular morphology and visual acuity in the comparison of age-related macular degeneration treatments trials.

  2013cited by this paper
• Pharmacogenetics for genes associated with age-related macular degeneration in the Comparison of AMD Treatments Trials (CATT).

  2013cited by this paper
• The association between complement component 2/complement factor B polymorphisms and age-related macular degeneration: a HuGE review and meta-analysis.

  2012cited by this paper
• Optical coherence tomography grading reproducibility during the Comparison of Age-related Macular Degeneration Treatments Trials.

  2012cited by this paper
• Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results.

  2012cited by this paper
• Heritability and genome-wide association study to assess genetic differences between advanced age-related macular degeneration subtypes.

  2012cited by this paper
• Prospective assessment of genetic effects on progression to different stages of age-related macular degeneration using multistate Markov models.

  2012cited by this paper
• Photographic assessment of baseline fundus morphologic features in the Comparison of Age-Related Macular Degeneration Treatments Trials.

  2012cited by this paper
• Ranibizumab and bevacizumab for neovascular age-related macular degeneration.

  2011cited by this paper
• CFH and ARMS2 variations in age-related macular degeneration, polypoidal choroidal vasculopathy, and retinal angiomatous proliferation.

  2010cited by this paper
• Genotypic influences on severity of exudative age-related macular degeneration.

  2010cited by this paper
• Genetic variants near TIMP3 and high-density lipoprotein–associated loci influence susceptibility to age-related macular degeneration

  2010cited by this paper
• Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC)

  2010cited by this paper
• Comprehensive analysis of complement factor H and LOC387715/ARMS2/HTRA1 variants with respect to phenotype in advanced age-related macular degeneration.

  2009cited by this paper
• GENOTYPE–PHENOTYPE ASSOCIATIONS IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

  2009cited by this paper
• Genotype-phenotype correlations for exudative age-related macular degeneration associated with homozygous HTRA1 and CFH genotypes.

  2008cited by this paper
• Association of complement factor H Y402H polymorphism with phenotype of neovascular age related macular degeneration in Israel

  2008cited by this paper
• Correlation between CFH Y402H and HTRA1 rs11200638 genotype to typical exudative age‐related macular degeneration and polypoidal choroidal vasculopathy phenotype in the Japanese population

  2008cited by this paper
• Complement factor H Y402H polymorphism and characteristics of exudative age‐related macular degeneration lesions

  2008cited by this paper
• Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to intravitreal bevacizumab.

  2007cited by this paper
• Clinical phenotypes associated with the complement factor H Y402H variant in age-related macular degeneration.

  2007cited by this paper
• Association of complement factor H Y402H gene polymorphism with different subtypes of exudative age-related macular degeneration.

  2007cited by this paper
• [Age-related macular degeneration].

  2006cited by this paper
• A cluster of deaths by footwear, 1894-1900

  2004cited by this paper
• Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3.

  2002cited by this paper
• Age-related macular degeneration.

  2000cited by this paper

• Linking the microbiome to the complement system in geographic atrophy.

  2026cites this paper
• Associations of PEDF Genetic Polymorphisms with Retinopathy of Prematurity.

  2025cites this paper
• Genetic context modulates aging and degeneration in the murine retina

  2025cites this paper
• Genetic context modulates aging and degeneration in the murine retina

  2024cites this paper
• A deep learning approach to explore the association of age‐related macular degeneration polygenic risk score with retinal optical coherence tomography: A preliminary study

  2024cites this paper
• Genetics in neovascular age‐related macular degeneration susceptibility and treatment response to anti‐VEGF intravitreal injection: A case series study

  2024cites this paper
• AMD and Stem Cell-Based Therapies

  2023cites this paper
• Construction of an Exudative Age-Related Macular Degeneration Diagnostic and Therapeutic Molecular Network Using Multi-Layer Network Analysis, a Fuzzy Logic Model, and Deep Learning Techniques: Are Retinal and Brain Neurodegenerative Disorders Related?

  2023cites this paper
• Next-Generation-Sequencing in der Augenheilkunde

  2022cites this paper
• Molecular Genetic Mechanisms in Age-Related Macular Degeneration

  2022cites this paper
• Neovascular Macular Degeneration: A Review of Etiology, Risk Factors, and Recent Advances in Research and Therapy

  2021cites this paper
• Gene polymorphisms associated with an increased risk of exudative age-related macular degeneration in a Spanish population

  2021cites this paper
• Transcriptomic Characterization of Human Choroidal Neovascular Membranes Identifies Calprotectin as a Novel Biomarker for Patients with Age-related Macular Degeneration.

  2020cites this paper
• Quality Control Measures and Validation in Gene Association Studies: Lessons for Acute Illness.

  2020cites this paper
• Analysis of genetic polymorphisms for age-related macular degeneration (AMD) in Chinese Tujia ethnic minority group

  2019cites this paper
• Association Between Perifoveal Drusen Burden Determined by OCT and Genetic Risk in Early and Intermediate Age-Related Macular Degeneration

  2019cites this paper
• Association between Drusen Burden Determined by OCT and Genetic Risk in Early and Intermediate Age-Related Macular Degeneration

  2019cites this paper
• The Utah Protocol for Postmortem Eye Phenotyping and Molecular Biochemical Analysis

  2019cites this paper
• ASSOCIATION BETWEEN ORAL IRON SUPPLEMENTATION AND RETINAL OR SUBRETINAL HEMORRHAGE IN THE COMPARISON OF AGE-RELATED MACULAR DEGENERATION TREATMENTS TRIALS.

  2018cites this paper
• A Deep Phenotype Association Study Reveals Specific Phenotype Associations with Genetic Variants in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 (AREDS2) Report No. 14.

  2018cites this paper
• Association of ARMS2/LOC387715 A69S, CFH Y402H, and CFH I62V polymorphisms with retinal angiomatous proliferation compared with typical age-related macular degeneration: a meta-analysis

  2017cites this paper
• Genetic Polymorphisms and the Phenotypic Characterization of Individuals with Early Age-Related Macular Degeneration

  2017cites this paper
• Genetics and the Variable Phenotype of Age-Related Macular Degeneration.

  2016cites this paper